AO: The analyst notes that there has been a shift towards neoliberal regimes of science policy and that scientists at government research centers perceive industry’s private R&D
AO: The analyst focused on private-public partnerships in the research and development of pharmaceuticals.
AO: The analyst cites STS work that has been concerned with the translational research that makes medical discoveries in the lab turn into medical interventions at the bedsite.
AO: A researcher who cares about their science contributing towards "social good"
AO: The analyst noted that “the multidimensional approach to collaboration at NCI was at the same time innovative in its ability to unite academia, industry, andgovernment science in...Read more
AO: The analyst is interested in understanding motivations for the development of HPV vaccines if profit is not the only answer.
AO: The analyst notes the specific interviews she held in her foot notes as well as archival materials cited such as meeting minutes and government reports. She does not talk about